Selected research
Market Analysis & Forecast
Global GMP-grade AAV Vector Manufacturing Service Market Analysis and Forecast 2026-2032
Market perspective
The global GMP-grade AAV Vector Manufacturing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for GMP-grade AAV Vector Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for GMP-grade AAV Vector Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for GMP-grade AAV Vector Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for GMP-grade AAV Vector Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of GMP-grade AAV Vector Manufacturing Service include Catalent, AGC Biologics, SK pharmteco, OXB, Forge Biologics, Viralgen, Andelyn Biosciences, Resilience and Advanced Therapies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for GMP-grade AAV Vector Manufacturing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of GMP-grade AAV Vector Manufacturing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for GMP-grade AAV Vector Manufacturing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the GMP-grade AAV Vector Manufacturing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GMP-grade AAV Vector Manufacturing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for GMP-grade AAV Vector Manufacturing Service revenue, projected growth trends, production technology, application and end-user industry.
GMP-grade AAV Vector Manufacturing Service Segment by Company
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Resilience
Advanced Therapies
IDT Biologika
Matica Bio
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech
Thermo Fisher Scientific
Lonza
Charles River Laboratories
GMP-grade AAV Vector Manufacturing Service Segment by Type
GMP Drug Substance Manufacturing
GMP Drug Substance and Fill-Finish
End-to-End CMC and Manufacturing
GMP-grade AAV Vector Manufacturing Service Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Other
GMP-grade AAV Vector Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP-grade AAV Vector Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP-grade AAV Vector Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP-grade AAV Vector Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of GMP-grade AAV Vector Manufacturing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of GMP-grade AAV Vector Manufacturing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP-grade AAV Vector Manufacturing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GMP Drug Substance Manufacturing
- GMP Drug Substance and Fill-Finish
- End-to-End CMC and Manufacturing
Applications
- Biotechnology Companies
- Pharmaceutical Companies
- Other
Companies covered
- Catalent
- AGC Biologics
- SK pharmteco
- OXB
- Forge Biologics
- Viralgen
- Andelyn Biosciences
- Resilience
- Advanced Therapies
- IDT Biologika
- Matica Bio
- Takara Bio
- VectorBuilder
- GenScript ProBio
- PackGene Biotech
- Thermo Fisher Scientific
- Lonza
- Charles River Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 GMP-grade AAV Vector Manufacturing Service Market by Type
- 1.2.1 Global GMP-grade AAV Vector Manufacturing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 GMP Drug Substance Manufacturing
- 1.2.3 GMP Drug Substance and Fill-Finish
- 1.2.4 End-to-End CMC and Manufacturing
- 1.3 GMP-grade AAV Vector Manufacturing Service Market by Application
- 1.3.1 Global GMP-grade AAV Vector Manufacturing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biotechnology Companies
- 1.3.3 Pharmaceutical Companies
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 GMP-grade AAV Vector Manufacturing Service Market Dynamics
- 2.1 GMP-grade AAV Vector Manufacturing Service Industry Trends
- 2.2 GMP-grade AAV Vector Manufacturing Service Industry Drivers
- 2.3 GMP-grade AAV Vector Manufacturing Service Industry Opportunities and Challenges
- 2.4 GMP-grade AAV Vector Manufacturing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global GMP-grade AAV Vector Manufacturing Service Market Perspective (2021-2032)
- 3.2 Global GMP-grade AAV Vector Manufacturing Service Growth Trends by Region
- 3.2.1 Global GMP-grade AAV Vector Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global GMP-grade AAV Vector Manufacturing Service Market Size by Region (2021-2026)
- 3.2.3 Global GMP-grade AAV Vector Manufacturing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global GMP-grade AAV Vector Manufacturing Service Revenue by Players
- 4.1.1 Global GMP-grade AAV Vector Manufacturing Service Revenue by Players (2021-2026)
- 4.1.2 Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global GMP-grade AAV Vector Manufacturing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global GMP-grade AAV Vector Manufacturing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global GMP-grade AAV Vector Manufacturing Service Key Players Headquarters & Area Served
- 4.4 Global GMP-grade AAV Vector Manufacturing Service Players, Product Type & Application
- 4.5 Global GMP-grade AAV Vector Manufacturing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global GMP-grade AAV Vector Manufacturing Service Market CR5 and HHI
- 4.6.3 2025 GMP-grade AAV Vector Manufacturing Service Tier 1, Tier 2, and Tier 3
5 GMP-grade AAV Vector Manufacturing Service Market Size by Type
- 5.1 Global GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 5.3 Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Type (2021-2032)
6 GMP-grade AAV Vector Manufacturing Service Market Size by Application
- 6.1 Global GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 6.3 Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Catalent
- 7.1.1 Catalent Company Information
- 7.1.2 Catalent Business Overview
- 7.1.3 Catalent GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Catalent GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.1.5 Catalent Recent Developments
- 7.2 AGC Biologics
- 7.2.1 AGC Biologics Company Information
- 7.2.2 AGC Biologics Business Overview
- 7.2.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.2.5 AGC Biologics Recent Developments
- 7.3 SK pharmteco
- 7.3.1 SK pharmteco Company Information
- 7.3.2 SK pharmteco Business Overview
- 7.3.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.3.5 SK pharmteco Recent Developments
- 7.4 OXB
- 7.4.1 OXB Company Information
- 7.4.2 OXB Business Overview
- 7.4.3 OXB GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 OXB GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.4.5 OXB Recent Developments
- 7.5 Forge Biologics
- 7.5.1 Forge Biologics Company Information
- 7.5.2 Forge Biologics Business Overview
- 7.5.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.5.5 Forge Biologics Recent Developments
- 7.6 Viralgen
- 7.6.1 Viralgen Company Information
- 7.6.2 Viralgen Business Overview
- 7.6.3 Viralgen GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Viralgen GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.6.5 Viralgen Recent Developments
- 7.7 Andelyn Biosciences
- 7.7.1 Andelyn Biosciences Company Information
- 7.7.2 Andelyn Biosciences Business Overview
- 7.7.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.7.5 Andelyn Biosciences Recent Developments
- 7.8 Resilience
- 7.8.1 Resilience Company Information
- 7.8.2 Resilience Business Overview
- 7.8.3 Resilience GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Resilience GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.8.5 Resilience Recent Developments
- 7.9 Advanced Therapies
- 7.9.1 Advanced Therapies Company Information
- 7.9.2 Advanced Therapies Business Overview
- 7.9.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.9.5 Advanced Therapies Recent Developments
- 7.10 IDT Biologika
- 7.10.1 IDT Biologika Company Information
- 7.10.2 IDT Biologika Business Overview
- 7.10.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.10.5 IDT Biologika Recent Developments
- 7.11 Matica Bio
- 7.11.1 Matica Bio Company Information
- 7.11.2 Matica Bio Business Overview
- 7.11.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.11.5 Matica Bio Recent Developments
- 7.12 Takara Bio
- 7.12.1 Takara Bio Company Information
- 7.12.2 Takara Bio Business Overview
- 7.12.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.12.5 Takara Bio Recent Developments
- 7.13 VectorBuilder
- 7.13.1 VectorBuilder Company Information
- 7.13.2 VectorBuilder Business Overview
- 7.13.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.13.5 VectorBuilder Recent Developments
- 7.14 GenScript ProBio
- 7.14.1 GenScript ProBio Company Information
- 7.14.2 GenScript ProBio Business Overview
- 7.14.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.14.5 GenScript ProBio Recent Developments
- 7.15 PackGene Biotech
- 7.15.1 PackGene Biotech Company Information
- 7.15.2 PackGene Biotech Business Overview
- 7.15.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.15.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.15.5 PackGene Biotech Recent Developments
- 7.16 Thermo Fisher Scientific
- 7.16.1 Thermo Fisher Scientific Company Information
- 7.16.2 Thermo Fisher Scientific Business Overview
- 7.16.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.16.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.16.5 Thermo Fisher Scientific Recent Developments
- 7.17 Lonza
- 7.17.1 Lonza Company Information
- 7.17.2 Lonza Business Overview
- 7.17.3 Lonza GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.17.4 Lonza GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.17.5 Lonza Recent Developments
- 7.18 Charles River Laboratories
- 7.18.1 Charles River Laboratories Company Information
- 7.18.2 Charles River Laboratories Business Overview
- 7.18.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue and Gross Margin (2021-2026)
- 7.18.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product Portfolio
- 7.18.5 Charles River Laboratories Recent Developments
8 North America
- 8.1 North America GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
- 8.2 North America GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 8.2.1 North America GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2026)
- 8.2.2 North America GMP-grade AAV Vector Manufacturing Service Revenue by Type (2027-2032)
- 8.3 North America GMP-grade AAV Vector Manufacturing Service Revenue Share by Type (2021-2032)
- 8.4 North America GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 8.4.1 North America GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2026)
- 8.4.2 North America GMP-grade AAV Vector Manufacturing Service Revenue by Application (2027-2032)
- 8.5 North America GMP-grade AAV Vector Manufacturing Service Revenue Share by Application (2021-2032)
- 8.6 North America GMP-grade AAV Vector Manufacturing Service Revenue by Country
- 8.6.1 North America GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021-2026)
- 8.6.3 North America GMP-grade AAV Vector Manufacturing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
- 9.2 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 9.2.1 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2026)
- 9.2.2 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Type (2027-2032)
- 9.3 Europe GMP-grade AAV Vector Manufacturing Service Revenue Share by Type (2021-2032)
- 9.4 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 9.4.1 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2026)
- 9.4.2 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Application (2027-2032)
- 9.5 Europe GMP-grade AAV Vector Manufacturing Service Revenue Share by Application (2021-2032)
- 9.6 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Country
- 9.6.1 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021-2026)
- 9.6.3 Europe GMP-grade AAV Vector Manufacturing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
- 10.2 China GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 10.2.1 China GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2026)
- 10.2.2 China GMP-grade AAV Vector Manufacturing Service Revenue by Type (2027-2032)
- 10.3 China GMP-grade AAV Vector Manufacturing Service Revenue Share by Type (2021-2032)
- 10.4 China GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 10.4.1 China GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2026)
- 10.4.2 China GMP-grade AAV Vector Manufacturing Service Revenue by Application (2027-2032)
- 10.5 China GMP-grade AAV Vector Manufacturing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
- 11.2 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 11.2.1 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2026)
- 11.2.2 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Type (2027-2032)
- 11.3 Asia GMP-grade AAV Vector Manufacturing Service Revenue Share by Type (2021-2032)
- 11.4 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 11.4.1 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2026)
- 11.4.2 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Application (2027-2032)
- 11.5 Asia GMP-grade AAV Vector Manufacturing Service Revenue Share by Application (2021-2032)
- 11.6 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Country
- 11.6.1 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021-2026)
- 11.6.3 Asia GMP-grade AAV Vector Manufacturing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue (2021-2032)
- 12.2 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Type (2027-2032)
- 12.3 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Application (2027-2032)
- 12.5 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Country
- 12.6.1 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA GMP-grade AAV Vector Manufacturing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst